52 97

Cited 0 times in

The Revo-i Robotic Surgical System in Advanced Pancreatic Surgery: A Second Non-Randomized Clinical Trial and Comparative Analysis to the da VinciTM System

Authors
 Ji Su Kim  ;  Munseok Choi  ;  Hyeo Seong Hwang  ;  Woo Jung Lee  ;  Chang Moo Kang 
Citation
 YONSEI MEDICAL JOURNAL, Vol.65(3) : 148-155, 2024-03 
Journal Title
YONSEI MEDICAL JOURNAL
ISSN
 0513-5796 
Issue Date
2024-03
MeSH
Humans ; Pancreas / surgery ; Pancreatic Neoplasms* / surgery ; Pancreaticoduodenectomy / adverse effects ; Postoperative Complications / epidemiology ; Postoperative Complications / surgery ; Prospective Studies ; Retrospective Studies ; Robotic Surgical Procedures* / adverse effects
Keywords
Robotics ; pancreatectomy ; pancreaticoduodenectomy
Abstract
Purpose: Numerous robot-assisted pancreatic surgery are being performed worldwide. This study aimed to evaluate the feasibili ty and safety of the Revo-i robot system (Meerecompany, Seoul, Republic of Korea) for advanced pancreatic surgery, and also compare this new system with the existing da VinciTM robot system (Intuitive Surgical, Sunnyvale, CA, USA) in the context of ro bot-assisted pancreaticoduodenectomy (RPD).

Materials and Methods: This study was a one-armed prospective clinical trial that assessed the Revo-i robot system for advanced pancreatic surgery. Ten patients aged 30 to 73 years were enrolled between December 2019 and August 2020. Postoperative out comes were retrospectively compared with those of the da VinciTM surgical system. From March 2017 to August 2020, a total of 47 patients who underwent RPD were analyzed retrospectively.

Results: In the prospective clinical trial, pancreaticoduodenectomy was performed in nine patients and one patient underwent central pancreatectomy. Among the 10 study participants, the incidence of major complications was 0% in hospital stay. There were eight postoperative pancreatic fistula (POPF) biochemical leaks (80%). In the retrospective analysis that compared the Revo-i and da VinciTM robotic systems, 10 patients underwent Revo-i RPD and 37 patients underwent da VinciTM RPD, with no significant differences in complication or POPF incidence rates between the two groups (p=0.695, p=0.317).

Conclusion: In this single-arm prospective study with short-term follow-up at a single institution, the Revo-i robotic surgical sys tem was safe and effective for advanced pancreatic surgery. Revo-i RPD is comparable to the da VinciTM RPD and is expected to have wide clinical application.
Files in This Item:
T202401721.pdf Download
DOI
10.3349/ymj.2023.0140
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
Yonsei Authors
Kang, Chang Moo(강창무) ORCID logo https://orcid.org/0000-0002-5382-4658
Lee, Woo Jung(이우정) ORCID logo https://orcid.org/0000-0001-9273-261X
Choi, Munseok(최문석) ORCID logo https://orcid.org/0000-0002-9844-4747
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/198807
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links